Atlas Trials

Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

Clinical trial NCT05184192 · COMPLETED

Trial details

NCT number
NCT05184192
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Olfactory DisorderAnosmiaHyposmiaParosmia
Start date
2022-01-10
Primary completion
2023-08-29
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.